Fluid Intake and vasopressin: Connecting the dots

Annals of Nutrition and Metabolism

Volumn 68, Issue 2, 2016, Pages 6-11

  Guelinckx, Isabelle ^a   Vecchio, Mariacristina ^a   Perrier, Erica T ^a   Lemetais, Guillaume ^a  

^a Hydration and Health Dept   (France)

Author keywords

Biomarkers; Chronic kidney disease; Copeptin; Diabetes; fluid intake; Hydration; Kidney; Metabolic syndrome; Urine osmolality; Vasopressin

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; VASOPRESSIN; ARGIPRESSIN; GLYCOPEPTIDE; VASOPRESSIN DERIVATIVE;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE MARKER; FLUID BALANCE; FLUID INTAKE; HEALTH; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; MEASUREMENT; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; URINE VOLUME; BIOLOGICAL MODEL; BLOOD; CHRONIC KIDNEY FAILURE; DRINKING; ELECTROLYTE BALANCE; HEALTH STATUS; HYPERGLYCEMIA; PHYSIOLOGY; URINE;

ARGININE VASOPRESSIN; BIOMARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DRINKING; GLYCOPEPTIDES; HEALTH STATUS; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 84975221239     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000446198     Document Type: Conference Paper

References (30)

1. Lukaszyk E, Malyszko J: Copeptin: pathophysiology and potential clinical impact. Adv Med Sci 2015; 60: 335-341.
2. Verbalis JG: Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab 2003; 17: 471-503.
3. Singh Ranger G: The physiology and emerging roles of antidiuretic hormone. Int J Clin Pract 2002; 56: 777-782.
4. Enhorning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton- Cheh C, Melander O: Plasma copeptin and the risk of diabetes mellitus. Circulation 2010; 121: 2102-2108.
5. Tasevska I, Enhorning S, Persson M, Nilsson PM, Melander O: Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart 2015; 102: 127-132.
6. Strippoli GF, Craig JC, Rochtchina E, Flood VM, Wang JJ, Mitchell P: Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) 2011; 16: 326- 334.
7. Sontrop JM, Dixon SN, Garg AX, Buendia- Jimenez I, Dohein O, Huang SH, Clark WF: Association between water intake, chronic kidney disease, and cardiovascular disease: A cross-sectional analysis of NHANES data. Am J Nephrol 2013; 37: 434-442.
8. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX: Urine volume and change in estimated GFR in a community- based cohort study. Clin J Am Soc Nephrol 2011; 6: 2634-2641.
9. Roussel R, Fezeu L, Bouby N, Balkau B, Lantieri O, Alhenc-Gelas F, Marre M, Bankir L; D.E.S.I.R. Study Group: Low water intake and risk for new-onset hyperglycemia. Diabetes Care 2011; 34: 2551-2554.
10. Perrier E, Vergne S, Klein A, Poupin M, Rondeau P, Le Bellego L, Armstrong LE, Lang F, Stookey J, Tack I: Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. Br J Nutr 2013; 109: 1678-1687.
11. Armstrong LE, Pumerantz AC, Fiala KA, Roti MW, Kavouras SA, Casa DJ, Maresh CM: Human hydration indices: Acute and longitudinal reference values. Int J Sport Nutr Exerc Metab 2010;20:145-153.
12. Palmer SC, Wong G, Iff S, Yang J, Jayaswal V, Craig JC, Rochtchina E, Mitchell P, Wang JJ, Strippoli GF: Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: A population-based longitudinal cohort study. Nephrol Dial Transplant 2014; 29: 1377-1384.
13. Perrier E, Klein A, Guelinckx I: Water from fluids is the main driver of total water intake in healthy French adults. Presented at the 38th National Nutrient Databank Conference, 2014. https://www.nutrientdataconf.org/PastConf/NDBC38/NNDC38-PosterAbstracts.pdf.
14. Enhorning S, Bankir L, Bouby N, Struck J, Hedblad B, Persson M, Morgenthaler NG, Nilsson PM, Melander O: Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective Malmö diet and cancer study cardiovascular cohort. Int J Obes (Lond) 2013; 37: 598-603.
15. Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH Jr, Kullo IJ: Plasma carboxy-terminal provasopressin (copeptin): A novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 2009; 94: 2558-2564.
16. Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili- Munoz N, Taveau C, Alhenc-Gelas F, et al: Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 2013; 36: 3639-3645.
17. Roussel R, Matallah N, Bouby N, El Boustany R, Potier L, Fumeron F, Mohammedi K, Balkau B, Marre M, Bankir L, et al: Plasma copeptin and decline in renal function in a cohort from the community: The prospective D.E.S.I.R. study. Am J Nephrol 2015; 42: 107-114.
18. Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby N, Bankir L, et al: Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 2014; 99: 4656-4663.
19. Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT: Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 2010; 77: 29-36.
20. Sontrop JM, Huang SH, Garg AX, Moist L, House AA, Gallo K, Clark WF: Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: Results from a pilot randomised controlled trial. BMJ Open 2015; 5:e008634.
21. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Muller B, Keller U, Christ-Crain M: Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 2007; 92: 3973-3978.
22. Morgenthaler NG, Struck J, Jochberger S, Dünser MW: Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008; 19: 43-49.
23. Fenske W, Stork S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B: Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 2009; 94: 123-129.
24. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A, Vogt B, Burnier M, Martin PY, Devuyst O, Bochud M: Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol 2015; 26: 1415-1425.
25. Robertson GL, Mahr EA, Athar S, Sinha T: Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973; 52: 2340-2352.
26. Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A: Twenty-fourhour urine osmolality as a physiological index of adequate water intake. Dis Markers 2015; 2015: 231063.
27. Bardosono S, Monrozier R, Permadhi I, Manikam NR, Pohan R, Guelinckx I: Total fluid intake assessed with a 7-day fluid record versus a 24-h dietary recall: A crossover study in Indonesian adolescents and adults. Eur J Nutr 2015; 54(suppl 2):17-25.
28. Özen AE, Bibiloni Mdel M, Pons A, Tur JA: Fluid intake from beverages across age groups: A systematic review. J Hum Nutr Diet 2015; 28: 417-442.
29. Ferreira-Pêgo C, Guelinckx I, Moreno LA, Kavouras SA, Gandy J, Martinez H, Bardosono S, Abdollahi M, Nasseri E, Jarosz A, Babio N, Salas-Salvado J: Total fluid intake and its determinants: cross-sectional surveys among adults in 13 countries worldwide. Eur J Nutr 2015; 54(suppl 2):35-43.
30. Guelinckx I, Ferreira-Pêgo C, Moreno LA, Kavouras SA, Gandy J, Martinez H, Bardosono S, Abdollahi M, Nasseri E, Jarosz A, Ma G, Carmuega E, Babio N, Salas-Salvado J: Intake of water and different beverages in adults across 13 countries. Eur J Nutr 2015; 54(suppl 2):45-55.